Gavis Pharma LLC is categorized under Wholesale Pharmaceutical Products in Somerset, NJ and active since 2013.
Gavis Pharma LLC was established in 2013, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact Veerappan Subramanian at the company’s single location by writing to 400 Campus Drive, Somerset, New Jersey NJ 08873 or by phoning (908) 603-6007. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Gavis Pharma LLC |
Contact Person: | Veerappan Subramanian |
Address: | 400 Campus Drive, Somerset, New Jersey 08873 |
Phone Number: | (908) 603-6007 |
Website Address: | gavispharma.com |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2013 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Wholesale Pharmaceutical Products |
SIC Code: | 5122 |
NAICS Code: | 424210 |
Share This Business: |
Gavis Pharma LLC was started in 2013 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Veerappan Subramanian for inquiries that concern Gavis Pharma LLC by calling the company number (908) 603-6007, as your correspondence is most welcome. Additionally, the physical location of the single location of Gavis Pharma LLC can be found at the coordinates 40.548705,-74.545231 as well as the street address 400 Campus Drive in Somerset, New Jersey 08873.
For its online presence, you may visit Gavis Pharma LLC’s website at gavispharma.com and engage with its social media outlets through on Twitter and on Facebook.